• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎的生存率和特定病因死亡率:哥本哈根县一项基于人群队列的随访研究

Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

作者信息

Winther Karen Vanessa, Jess Tine, Langholz Ebbe, Munkholm Pia, Binder Vibeke

机构信息

Department of Medical Gastroenterolgy C, Herlev Hospital, University of Copenhagen, Denmark.

出版信息

Gastroenterology. 2003 Dec;125(6):1576-82. doi: 10.1053/j.gastro.2003.09.036.

DOI:10.1053/j.gastro.2003.09.036
PMID:14724807
Abstract

BACKGROUND & AIMS: A population-based cohort from Copenhagen County comprising 1160 patients diagnosed with ulcerative colitis between 1962 and 1987 was followed-up until 1997 to describe survival and cause-specific mortality.

METHODS

Observed vs. expected deaths were presented as standardized mortality ratio (SMR) with exact 95% confidence intervals (CI) calculated by using individually registered person-years at risk and Danish 1995 mortality rates. Cumulative survival curves were calculated.

RESULTS

A total of 261 deaths occurred, not significantly different from the expected number of 249 (SMR, 1.05; 95% CI, 0.92-1.19). The median age at death among men was 70 years (range, 6-96 years) and among women 74 years (range, 25-96 years). Twenty-five deaths (9.6%) were caused by complications to ulcerative colitis, mostly infectious and cardiovascular postoperative complications. Patients older than 50 years of age at diagnosis and with extensive colitis showed an increased mortality within the first 2 years because of ulcerative colitis-associated causes. The mortality from colorectal cancer was not increased and that of cancer in general was significantly lower than expected: 50 vs. 71 (SMR, 0.70; 95% CI, 0.52-0.93). A significantly increased mortality from pulmonary embolism and pneumonia was found. Among women only, death from genitourinary tract diseases and suicide was significantly increased.

CONCLUSIONS

Despite an overall normal life expectancy for patients with ulcerative colitis, patients >50 years of age and with extensive colitis at diagnosis had increased mortality within the first 2 years after diagnosis, owing to colitis-associated postoperative complications and comorbidity.

摘要

背景与目的

对哥本哈根郡一个基于人群的队列进行研究,该队列包含1962年至1987年间确诊为溃疡性结肠炎的1160例患者,随访至1997年,以描述生存率和死因特异性死亡率。

方法

观察到的死亡数与预期死亡数之比以标准化死亡率(SMR)表示,并使用个体登记的风险人年数和丹麦1995年死亡率计算精确的95%置信区间(CI)。计算累积生存曲线。

结果

共发生261例死亡,与预期的249例无显著差异(SMR,1.05;95%CI,0.92 - 1.19)。男性死亡的中位年龄为70岁(范围6 - 96岁),女性为74岁(范围25 - 96岁)。25例死亡(9.6%)由溃疡性结肠炎并发症导致,主要是感染性和心血管术后并发症。诊断时年龄大于50岁且患有广泛性结肠炎的患者,在最初2年内因溃疡性结肠炎相关原因导致的死亡率增加。结直肠癌的死亡率未升高,总体癌症死亡率显著低于预期:50例 vs. 71例(SMR,0.70;95%CI,0.52 - 0.93)。发现肺栓塞和肺炎的死亡率显著增加。仅在女性中,泌尿生殖道疾病和自杀导致的死亡显著增加。

结论

尽管溃疡性结肠炎患者的总体预期寿命正常,但诊断时年龄大于50岁且患有广泛性结肠炎的患者,在诊断后的最初2年内,由于结肠炎相关的术后并发症和合并症,死亡率增加。

相似文献

1
Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.溃疡性结肠炎的生存率和特定病因死亡率:哥本哈根县一项基于人群队列的随访研究
Gastroenterology. 2003 Dec;125(6):1576-82. doi: 10.1053/j.gastro.2003.09.036.
2
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.溃疡性结肠炎:诊断10年后欧洲全人群队列研究显示死亡率未升高。
Gut. 2007 Apr;56(4):497-503. doi: 10.1136/gut.2006.101519. Epub 2006 Oct 6.
3
Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County.溃疡性结肠炎患者患癌的长期风险:一项来自哥本哈根郡的基于人群的队列研究。
Clin Gastroenterol Hepatol. 2004 Dec;2(12):1088-95. doi: 10.1016/s1542-3565(04)00543-9.
4
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study.意大利溃疡性结肠炎患者的生存情况及死亡原因。一项意大利胃肠病学会全国性研究。
Dig Liver Dis. 2001 Nov;33(8):686-92. doi: 10.1016/s1590-8658(01)80046-3.
5
Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study.炎症性肠病的生存率和特定病因死亡率:一项基于人群的队列研究。
Gastroenterology. 1996 May;110(5):1339-45. doi: 10.1053/gast.1996.v110.pm8613037.
6
Ulcerative colitis and colorectal cancer: a follow-up study in Fukuoka, Japan.溃疡性结肠炎与结直肠癌:日本福冈的一项随访研究
Int J Epidemiol. 1999 Aug;28(4):609-13. doi: 10.1093/ije/28.4.609.
7
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.溃疡性结肠炎和克罗恩病患者全因死亡率和癌症死亡率的不同模式:1978 - 2001年佛罗伦萨炎症性肠病研究
Gut. 2004 Sep;53(9):1309-13. doi: 10.1136/gut.2003.031476.
8
Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010.溃疡性结肠炎和克罗恩病患者队列中的全因死亡率和癌症死亡率:佛罗伦萨炎症性肠病研究,1978 - 2010年
Dig Liver Dis. 2016 Oct;48(10):1162-7. doi: 10.1016/j.dld.2016.07.008. Epub 2016 Jul 15.
9
Prognosis and mortality of ulcerative colitis in Stockholm County, 1955-1979.1955 - 1979年斯德哥尔摩郡溃疡性结肠炎的预后与死亡率
Scand J Gastroenterol. 1987 Oct;22(8):907-13. doi: 10.3109/00365528708991934.
10
Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden.瑞典马尔默非选择性溃疡性结肠炎和不确定性结肠炎患者的结直肠癌发病率及全因死亡率
Int J Colorectal Dis. 1995;10(2):117-22. doi: 10.1007/BF00341210.

引用本文的文献

1
Time-adjusted average Mayo endoscopic score predicts the risk of disease extent progression in distal ulcerative colitis patients.时间调整后的平均梅奥内镜评分可预测远端溃疡性结肠炎患者疾病范围进展的风险。
Gastroenterol Rep (Oxf). 2022 May 18;10:goac019. doi: 10.1093/gastro/goac019. eCollection 2022.
2
Impact of Epithelial Cell Shedding on Intestinal Homeostasis.上皮细胞脱落对肠道稳态的影响。
Int J Mol Sci. 2022 Apr 9;23(8):4160. doi: 10.3390/ijms23084160.
3
Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis.
维得利珠单抗与 IBD 术后并发症的关联:系统评价和荟萃分析。
Int J Colorectal Dis. 2021 Oct;36(10):2081-2092. doi: 10.1007/s00384-021-04017-2. Epub 2021 Sep 1.
4
Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis.基于基线临床数据的机器学习可预测溃疡性结肠炎患者在第 22 周时 vedolizumab 的疗效。
Sci Rep. 2021 Aug 12;11(1):16440. doi: 10.1038/s41598-021-96019-x.
5
Rho GTPases as Key Molecular Players within Intestinal Mucosa and GI Diseases.Rho GTPases 作为肠道黏膜和胃肠道疾病中的关键分子参与者。
Cells. 2021 Jan 4;10(1):66. doi: 10.3390/cells10010066.
6
Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study.哈萨克斯坦炎症性肠病的患病率及患者认知情况:一项横断面研究
Intest Res. 2020 Oct;18(4):430-437. doi: 10.5217/ir.2019.00099. Epub 2020 Sep 29.
7
Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.患者对吸烟与炎症性肠病的看法:与欧洲克罗恩病和溃疡性结肠炎协会合作开展的在线调查
World J Gastroenterol. 2020 Aug 7;26(29):4343-4355. doi: 10.3748/wjg.v26.i29.4343.
8
Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products.重新审视炎症性肠病:病理学、治疗方法、挑战及新兴疗法,包括来自天然产物的药物先导物
J Clin Med. 2020 Apr 28;9(5):1273. doi: 10.3390/jcm9051273.
9
Evaluation of Invasive Intra-abdominal Candidiasis in Crohn Disease at the Time of Surgery.克罗恩病手术时侵袭性腹腔念珠菌病的评估
Ann Coloproctol. 2020 Feb;36(1):12-16. doi: 10.3393/ac.2018.10.15.2. Epub 2020 Mar 3.
10
Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis.溃疡性结肠炎患者患结直肠癌的风险:一项系统评价与Meta分析
Gastroenterol Res Pract. 2019 Nov 3;2019:5363261. doi: 10.1155/2019/5363261. eCollection 2019.